<DOC>
	<DOCNO>NCT00772395</DOCNO>
	<brief_summary>Can risedronate give weekly 6 month prevent periprosthetic bone loss uncemented total hip arthroplasty ?</brief_summary>
	<brief_title>Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip Arthroplasty</brief_title>
	<detailed_description>Periprosthetic bone loss total hip arthroplasty main factor limit longevity implant use treatment osteoarthritis . Bone loss lead implant destabilization . Bisphosphonates , give approximately 6 month THA man prevent bone loss lead longer implant fixation lower incidence aseptic prosthesis loosening . We perform clinical trial risedronate investigate influence periprosthetic bone loss around uncemented femoral stem .</detailed_description>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>Patients wait list total hip arthroplasty Primary osteoarthritis Osteoarthritis secondary congenital dislocation hip Rheumatoid arthritis Bisphosphonate treatment Osteomalacia Hypocalcemia Previous surgery affect hip</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Periprosthetic bone loss risedronate bisphosphonates</keyword>
</DOC>